Thyroid Medication Doesn’t Improve Outcomes in Women That Are Pregnant

Levothyroxine, a thyroid medication doesn’t improve pregnancy outcomes in females from China who have been undergoing in vitro fertilization and embryo transfer for infertility, reveals new research.

Ladies who test positive for thyroid autoantibodies are considered to be at greater risk for miscarriage.

‘Levothyroxine doesn’t improve outcomes in women that are pregnant who’ve thyroid autoantibodies.’

Limited studies with conflicting results exist on whether levothyroxine treatment can improve pregnancy outcomes among ladies who test positive for thyroid autoantibodies but have normal thyroid function.
About 600 ladies who had normal thyroid function and tested positive for thyroid autoantibodies treated for infertility in a Beijing hospital from September 2012 to March 2017.

Half the ladies received levothyroxine treatment and half didn’t. Investigators measured rates of miscarriage, pregnancy and live-births.

It was a randomized medical trial (RCT), which enables for that most powerful inferences to make concerning the true aftereffect of an intervention. However, not every RCT results could be replicated in tangible-world settings because patient characteristics or any other variables may vary from individuals which were studied within the RCT.

The authors were Jie Qiao, M.D., Ph.D., Tianpei Hong, M.D., Ph.D., from the Peking College Third Hospital, Beijing, and coauthors.

There wasn’t any important variations between groups within the proportion of ladies who miscarried, grew to become pregnant, or delivered live babies.

This research would be a single-center trial. Caution ought to be used when extending this lead to other patient populations.

Source: Eurekalert

Leave a Reply

Your email address will not be published. Required fields are marked *